Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ensysce Biosciences (ENSC) Return on Capital Employed (2020 - 2025)

Ensysce Biosciences (ENSC) has disclosed Return on Capital Employed for 6 consecutive years, with 5.33% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed fell 341.0% to 5.33% in Q3 2025 year-over-year; TTM through Sep 2025 was 5.33%, a 341.0% decrease, with the full-year FY2024 number at 3.46%, up 766.0% from a year prior.
  • Return on Capital Employed was 5.33% for Q3 2025 at Ensysce Biosciences, down from 2.58% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 29.0% in Q4 2023 to a low of 23.79% in Q1 2023.
  • A 5-year average of 1.85% and a median of 2.58% in 2025 define the central range for Return on Capital Employed.
  • Biggest YoY gain for Return on Capital Employed was 1935bps in 2024; the steepest drop was -3027bps in 2024.
  • Ensysce Biosciences' Return on Capital Employed stood at 5.81% in 2021, then skyrocketed by 75bps to 10.19% in 2022, then surged by 185bps to 29.0% in 2023, then plummeted by -104bps to 1.27% in 2024, then tumbled by -318bps to 5.33% in 2025.
  • Per Business Quant, the three most recent readings for ENSC's Return on Capital Employed are 5.33% (Q3 2025), 2.58% (Q2 2025), and 2.05% (Q1 2025).